Normalizing sleep quality disturbed by psychiatric polypharmacy: a single patient open trial (SPOT).

ABSTRACT: There is a growing interest in personalized and preventive medicine initiatives that leverage serious patient engagement, such as those initiated and pursued among participants in the quantified-self movement. However, many of the self-assessments that result are not rooted in good scientific practices, such as exploiting controls, dose escalation strategies, multiple endpoint monitoring, etc. Areas where individual monitoring and health assessments have great potential involve sleep and behavior, as there are a number of very problematic sleep and behavior-related conditions that are hard to treat without personalization. For example, winter depression or seasonal affective disorder (SAD) is a serious, recurrent, atypical depressive disorder impacting millions each year. In order to preve

SUBMITTER: Magnuson V 

PROVIDER: S-EPMC5527988 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature